Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

Danazol

Status:

Phase 2

Condition:

Telomere Disease

Intervention Type:

Oral Drug

Funder Type:

NIH | US Federal Agency

Drug Details

Danazol is a 17beta-hydroxy steroid and a terminal acetylenic compound.

Study Purpose

Telomeres are found on the end of chromosomes in DNA. Some people with short telomeres or other gene changes can develop diseases of the bone marrow, lung, and liver. Researchers want to see if low doses of the hormone drug danazol can help. To study the safety and effect of low dose danazol.

Find a Clinical Trial